Copay coupons get the Inspector General treatment

Tracy Staton

The HHS 's office says the fine print isn't enough to safeguard against Medicare recipients' coupon use. Drugmakers have to do more–or risk violating antikickback laws.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS